Cambridge Investment Research Advisors, Inc. Femasys Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$1.3 - $2.76 $38,845 - $82,471
-29,881 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$1.76 - $3.99 $52,590 - $119,225
29,881 New
29,881 $67,000

Others Institutions Holding FEMY

# of Institutions
26
Shares Held
1.57M
Call Options Held
0
Put Options Held
0
View Full List

About FEMASYS INC

FEMY Quotes by TradingView
  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $12.8M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email